Cytokine production in major depression. The role of proinflammatory cytokines and Th1/Th2 dysfunction

Central-European Journal of Immunology

Volumn 27, Issue 3, 2002, Pages 84-89

  Kamińska, Teresa ^a   Marmurowska Michalłowska, Halina ^b   Dubas Ślemp, Halina ^b   Wysocka, Alicja ^b   Kandefer Szerszeń, Martyna ^a  

^a MARIA CURIE SK ODOWSKA UNIVERSITY   (Poland)

^b University of Medicine at Lublin   (Poland)

Author keywords

IFN ; IFN ; IL 10; IL 1 ; IL 2; IL 4; IL 6; Major depression; TNF

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNITY; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MAJOR DEPRESSION; MALE; MONOCYTE; STATISTICAL SIGNIFICANCE; TH1 CELL; TH2 CELL;

EID: 17144474419     PISSN: 14263912     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Connor TJ, Leonard BE (1998): Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sci 62: 583-606.
2. Corrigan FM (1998): Depression: immunological resignation of the will to live? Med Hypotheses 50: 9-18.
3. Hickie I, Hickie C, Bennett B, Wakefield D, Silove D, Mitchell P, Lloyd A (1995): Biochemical correlates of in vivo cell- mediated immune dysfunction in patients with depression: a preliminary report. Int J Immunopharmacol 17: 685-690.
4. Miller GE. Cohen S, Herbert TB (1999): Pathways linking major depression and immunity in ambulatory female patients. Psychosom Med 61: 850-860.
5. Maes M, Vandoolaeghe E, Van Hunsel F, Bril T, Demedts P, Wauters A, Neels H (1997): Immune disturbances in treatment-resistant depression: modulation by antidepressive treatments. Human Psychopharmacol 12: 153-162.
6. Slużewska A. Rybakowski J, Bosmans E, Sobieska M, Berghmans R, Maes M, Wiktorowicz K (1996): Indicators of immune activation in major depression. Psychiatr Res 64: 161-167.
7. Slużewska A, Rybakowski J, Sobieska M. Wiktorowicz K (1996): Concentrations and microheterogeneity glycophorms of alpha-1-acid glycoprotein in major depression. J Affective Disord 39: 149-155.
8. Song C, Dinan T, Leonard BE (1994): Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls. J Affective Disord 30: 283-288.
9. Frommberger UH, Bauer J, Haselbauer P. Fraulin A, Riemann D, Berger M (1997): Interleukin 6 (IL-6) plasma levels in depression and schizophrenia: Comparison between acute state and after remission. Eur Arch Psychiatry Clin Neurosci 247: 228-233.
10. Maes M, Bosmans E, Meltzer HY, Charpe S, Suy E (1993): Interleukin-1: A putative mediator of HPA-axis hyperactivity in major depression? Am J Psychiatry 150: 1189-1193.
11. Maes M, Meltzer HY, Bosmans E, Bergmans R, Vandoolaeghe E, Ranjan R, Desnyder R (1995): Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferring receptor in major depression. J Affective Disord 34: 301-309.
12. Owen BM, Eccleston D, Ferrier IN, Young AH (2001): Raised levels of plasma IL-1 beta in major and postviral depression. Acta Psychiatr Scand 103: 161-162.
13. Seidel A, Arolt V. Hunstiger M, Rink L, Behnish A, Kirchner H (1996): Increased CD56+ natural killer cells and related cytokines in major depression. Clin Immunol Immunopathol 78: 83-85.
14. Slużewska A, Rybakowski J, Sobieska M, Bosmans E, Pollet H, Wiktorowicz K (1995): Increased levels of alpha-1-acid glycoprotein and IL-6 in refractory depression. Depression 3: 170-175.
15. Maes M, Scharpe S, Meltzer HY, Okayli G, Bosmans E, D'Hondt P. Vanden Bossche B, Cosyns P (1994): Increased neopterin and interferon-γ secretion and lower availability of L-tryptophan in major depression: Further evidence for activation of cell-mediated immunity. Psychiatr Res 54: 143-160.
16. Maes M, Song C, Lin AH, Bonaccorso S, Kenis G, De Jong R, Bosmans E, Scharpe S (1999): Negative immunoregulatory effects of antidepressants: Inhibition of interferon-γ and stimulation of interleukin- 10 secretion. Neuropsychopharmacology 20: 370-379.
17. Seidel A, Arolt V, Hunstiger M, Rink L, Behnisch A, Kirchner H (1995): Cytokine production and serum proteins in depression. Scand J Immunol 41: 534-538.
18. Weizman R, Laor N, Podliszewski E, Notti I, Djaldetti M, Bessler H (1995): Cytokine production in major depressed patients before and after clomipramine treatment. Biological Psychiatry 35: 42-47.
19. Inglot A, Leszek J, Piasecki E, Sypula A (1994): Interferon responses in schizophrenia and major depressive disorders. Biol. Psychiatry 35: 464-473.
20. th ed., Washington, DC, American Psychiatric Press.
21. Hamilton M. (1960): A rating scale for depression. J Neurology, Neurosurgery Psychiatry 23: 56-61.
22. Kirchner H, Kleinicke C, Diegel W (1982): A whole blood technique for testing production of human interferon by leukocytes. Immunol Methods 48: 213-219.
23. Anisman H, Ravidran AV, Griffith J, Merali Z (1999): Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features. Molecular Psychiatry, 4: 182-188
24. Brambilla F, Maggioni M (1998): Blood levels of cytokines in elderly patients with major depressive disorder. Acta Psychiatr Scand 97: 309-313.
25. Natelson BH, Zhou XD, LaManca JJ, Ottenweller JE, Tiersky L, LeLuca J, Gause WC (1999): Is depression associated with immune activation? J Affective Disord 53: 179-184.
26. Haus E, Smolensky MH (1999): Biological rhythms in the immune system. Chronobiol Int 16: 581-622.
27. Kubera M, Kenis G, Bosmans E, Zieba A, Dudek D, Nowak G, Maes M (2000): Plasma levels of interleukin-6. interleukin 10. and interleukin-1 receptor antagonist in depression: comparison between the acute state and after remission. Polish J Pharmacol 52: 237-241.
28. Iv EC (2001): Interferons: potential roles in affect. Med Hypotheses 56: 558-566.
29. O'Shea JJ and Visconti R (2000): Type 1 IFNs and regulation of Thl responses: enigmas both resolved and emerge. Nature Immunology 1: 17-19.
30. Sinigaglia F, D'Ambrosio D and Rogge L (1999): Type I interferons and the Th1/Th2 paradigm. Develop. Comp Immunol 23: 657-663.
31. Maes M, Smith R, Scharpe S (1995): The monocyte-T-lymphocyte hypotheses of major depression Psychoneuroendocrinology 20: 111-116.
32. Cavaillon JM (1996): Les Cytokines, Cavaillon JM (ed.), Paris, Masson 184-199.